Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Amag Pharmaceuticals (AMAG)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 586,835
  • Shares Outstanding, K 34,540
  • Annual Sales, $ 609,950 K
  • Annual Income, $ -199,230 K
  • 36-Month Beta 0.23
  • Price/Sales 0.98
  • Price/Cash Flow N/A
  • Price/Book 0.78

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 7 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/18
See More
  • Average Estimate -0.81
  • Number of Estimates 2
  • High Estimate -0.79
  • Low Estimate -0.83
  • Prior Year 0.10
  • Growth Rate Est. (year over year) -910.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
16.32 +2.94%
on 12/14/18
19.44 -13.58%
on 12/04/18
-0.24 (-1.41%)
since 11/14/18
3-Month
16.32 +2.94%
on 12/14/18
23.77 -29.32%
on 10/17/18
-5.65 (-25.17%)
since 09/14/18
52-Week
11.95 +40.59%
on 02/09/18
26.10 -35.63%
on 08/13/18
+3.00 (+21.74%)
since 12/14/17

Most Recent Stories

More News
AMAG to Acquire Ciraparantag Maker Perosphere Pharmaceuticals

AMAG inks a deal to buy Perosphere Pharmaceuticals, which will add the latter's investigational candidate, ciraparantag, to its portfolio.

ILMN : 326.46 (-2.44%)
GILD : 65.57 (-2.64%)
AMAG : 16.80 (-1.12%)
ALXN : 109.43 (-2.67%)
AMAG Pharmaceuticals Enters Into Definitive Merger Agreement to Acquire Perosphere Pharmaceuticals

Next Generation Anticoagulant Reversal Agent, Ciraparantag, Will Add Innovative Clinical Stage Asset to AMAG's Hematology Portfolio

AMAG : 16.80 (-1.12%)
Global Intravenous (IV) Iron Drugs Market: Size, Trends and Forecasts (2018-2022) - Featuring Vifor Pharma, Sanofi, AMAG Pharmaceuticals, and Daiichi Sankyo - ResearchAndMarkets.com

The "Global Intravenous (IV) Iron Drugs Market: Size, Trends and Forecasts (2018-2022)" report has been added to ResearchAndMarkets.com's offering.

GNHAF : 127.9672 (-1.75%)
AMAG : 16.80 (-1.12%)
Study of Feraheme demonstrates Improvements in Fatigue and Quality Of Life in Iron Deficiency Anemia Patients

AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) today announced that research supported by the Company, "Sustained Improvements in Fatigue and Quality of Life in Iron Deficiency Anemia Patients Following a Single...

AMAG : 16.80 (-1.12%)
AMAG Pharmaceuticals Awards Four Grants to Further Research in Preterm Birth and Preeclampsia

As part of the company's annual grant program to support research to reduce preterm birth and preeclampsia and associated complications, AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG) today announced it has...

AMAG : 16.80 (-1.12%)
AMAG's Label Expansion of Lead Products Raises Share Price

AMAG's (AMAG) label expansion efforts for Feraheme and Makena are encouraging.

MRK : 76.48 (-3.20%)
JNJ : 133.00 (-10.04%)
AMAG : 16.80 (-1.12%)
BMY : 52.12 (-2.83%)
Detailed Research: Economic Perspectives on KB Home, Lennox International, CorVel, Acorda Therapeutics, PROS, and AMAG Pharmaceuticals -- What Drives Growth in Today's Competitive Landscape

In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of KB Home (NYSE:KBH), Lennox...

KBH : 19.65 (-0.91%)
CRVL : 64.26 (-2.38%)
ACOR : 16.18 (+1.25%)
PRO : 30.70 (-1.76%)
AMAG : 16.80 (-1.12%)
LII : 213.88 (-1.55%)
AMAG Posts Wider-Than-Expected Q3 Loss, Beats on Revenues

AMAG reports wider than expected loss in the third quarter of 2018. The company completed the sale of Cord Blood Registry in August 2018.

MRK : 76.48 (-3.20%)
LLY : 111.93 (-2.55%)
AMAG : 16.80 (-1.12%)
BMY : 52.12 (-2.83%)
AMAG Pharmaceuticals (AMAG) Reports Q3 Loss, Tops Revenue Estimates

AMAG Pharmaceuticals (AMAG) delivered earnings and revenue surprises of 0.00% and 3.88%, respectively, for the quarter ended September 2018. Do the numbers hold clues to what lies ahead for the stock?

AMAG : 16.80 (-1.12%)
AMAG Pharmaceuticals Announces Third Quarter 2018 Financial Results and Provides Corporate Update

Achieved strong third quarter financial performance and increased full year 2018 guidance

AMAG : 16.80 (-1.12%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 96% Sell with a Strongest short term outlook on maintaining the current direction.

Longer term, the trend strength is Maximum. Long term indicators fully support a continuation of the trend.

The market is in highly oversold territory. Beware of a trend reversal.

See More Share

Trade AMAG with:

Business Summary

AMAG Pharmaceuticals, Inc. is a biopharmaceutical company that utilizes its proprietary nanoparticle technology for the development and commercialization of therapeutic iron compounds to treat anemia and novel imaging agents to aid in the diagnosis of cancer and cardiovascular disease. Ferumoxytol, the...

See More

Key Turning Points

2nd Resistance Point 17.68
1st Resistance Point 17.24
Last Price 16.80
1st Support Level 16.34
2nd Support Level 15.88

See More

52-Week High 26.10
Fibonacci 61.8% 20.69
Fibonacci 50% 19.02
Fibonacci 38.2% 17.36
Last Price 16.80
52-Week Low 11.95

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar